These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 618775)

  • 61. Adaptive changes of the striatal dopamine system induced by repeated administration of neuroleptics and ergot derivatives.
    Bürki HR
    Adv Biochem Psychopharmacol; 1980; 24():65-8. PubMed ID: 6105806
    [No Abstract]   [Full Text] [Related]  

  • 62. Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens.
    Tassin JP; Simon H; Hervé D; Blanc G; Le Moal M; Glowinski J; Bockaert J
    Nature; 1982 Feb; 295(5851):696-8. PubMed ID: 6276780
    [No Abstract]   [Full Text] [Related]  

  • 63. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
    Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract]   [Full Text] [Related]  

  • 64. Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites.
    Howlett DR; Nahorski SR
    Brain Res; 1979 Jan; 161(1):173-8. PubMed ID: 758968
    [No Abstract]   [Full Text] [Related]  

  • 65. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Lew JY; Hata F; Ohashi T; Goldstein M
    J Neural Transm; 1977; 41(2-3):109-21. PubMed ID: 21229
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dopamine receptor topography. Characterization of antagonist requirements of striatal dopamine-sensitive adenylate cyclase using protoberberine alkaloids.
    Clement-Cormier YC; Meyerson LR; Phillips H; Davis VE
    Biochem Pharmacol; 1979 Oct; 28(20):3123-9. PubMed ID: 518711
    [No Abstract]   [Full Text] [Related]  

  • 67. Presynaptic dopamine and serotonin receptors modulating tyrosine hydroxylase activity in synaptosomes of the nucleus accumbens of rats.
    Hetey L; Kudrin VS; Shemanow AY; Rayevsky KS; Oelssner W
    Eur J Pharmacol; 1985 Jul; 113(1):1-10. PubMed ID: 2864259
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of some ergot alkaloids on dopamine receptors of molluscan smooth muscle.
    Ishii Y; Takayanagi I
    J Pharmacobiodyn; 1982 Sep; 5(9):748-50. PubMed ID: 7153848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.
    Pycock CJ; Kerwin RW; Carter CJ
    Nature; 1980 Jul; 286(5768):74-6. PubMed ID: 7393327
    [No Abstract]   [Full Text] [Related]  

  • 70. The effects of 2-chloro-11-(4-methyl-l-piperazinyl) dibenz(b,f)(1,4)oxazepine (loxapine) and its derivatives on the dopamine-sensitive adenylate cyclase of rat striatal homogenates.
    Coupet J; Szucs VA; Greenblatt EN
    Brain Res; 1976 Oct; 116(1):177-80. PubMed ID: 974768
    [No Abstract]   [Full Text] [Related]  

  • 71. The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum.
    Jackson DM; Andén NE; Engel J; Liljequist S
    Psychopharmacologia; 1975 Dec; 45(2):151-5. PubMed ID: 1240636
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
    Thomas TN; Zemp JW
    J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
    [No Abstract]   [Full Text] [Related]  

  • 73. Neurochemical study of mafoprazine, a new phenylpiperazine derivative.
    Fukuchi I; Kawashima K; Matsuoka Y; Ishida R
    Jpn J Pharmacol; 1988 May; 47(1):51-61. PubMed ID: 3411821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Calcium-dependent regulator involvement in the dopamine receptors supersensitivity.
    Lucchelli A
    Pharmacol Res Commun; 1980 Jul; 12(7):709-17. PubMed ID: 7190711
    [No Abstract]   [Full Text] [Related]  

  • 75. Adenylate cyclase from various dopaminergic areas of the brain and the action of loxapine.
    Clement-Cormier YC
    Adv Exp Med Biol; 1977; 90():183-90. PubMed ID: 930743
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stratial content of Ca2+-dependent regulator protein and dopaminergic receptor function.
    Lucchelli A; Guidotti A; Costa E
    Brain Res; 1978 Oct; 155(1):130-5. PubMed ID: 28815
    [No Abstract]   [Full Text] [Related]  

  • 77. 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives.
    Creese I; Manian AA; Prosser TD; Snyder SH
    Eur J Pharmacol; 1978 Feb; 47(3):291-6. PubMed ID: 631182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Different dopamine stimulation of adenylate cyclase in striatum and mesolimbic area of rats treated with chronic chlorpromazine.
    Kaneno S; Watanabe S; Toru M; Shimazono Y
    Brain Res; 1978 Aug; 152(2):396-400. PubMed ID: 679034
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.
    Hyttel J
    Life Sci; 1978 Aug; 23(6):551-5. PubMed ID: 29194
    [No Abstract]   [Full Text] [Related]  

  • 80. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum.
    Garau L; Govoni S; Stefanini E; Trabucchi M; Spano PF
    Life Sci; 1978 Oct; 23(17-18):1745-50. PubMed ID: 723447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.